Scientific DataBioinformaticsPeer-reviewed journal article
Epigenomic profiling of neuroblastoma cell lines
Kristen A. Upton, Apexa ModiiD, Khushbu PateliD, Nathan M. KendserskyiD, Karina L. ConkriteiD, Robyn T. SussmaniD, Gregory P. WayiD, Rebecca N. Adams, Gregory I. Sacks, Paolo M. FortinaiD, Sharon J. DiskiniD, John M. MarisiD, Jo Lynne RokitaiD
Abstract
Understanding the aberrant transcriptional landscape of neuroblastoma is necessary to provide insight to the underlying influences of the initiation, progression and persistence of this developmental cancer. Here, we present chromatin immunoprecipitation sequencing (ChIP-Seq) data for the oncogenic transcription factors, MYCN and MYC, as well as regulatory histone marks H3K4me1, H3K4me3, H3K27Ac, and H3K27me3 in ten commonly used human neuroblastoma-derived cell line models. In addition, for all of the profiled cell lines we provide ATAC-Seq as a measure of open chromatin. We validate specificity of global MYCN occupancy in MYCN amplified cell lines and functional redundancy of MYC occupancy in MYCN non-amplified cell lines. Finally, we show with H3K27Ac ChIP-Seq that these cell lines retain expression of key neuroblastoma super-enhancers (SE). We anticipate this dataset, coupled with available transcriptomic profiling on the same cell lines, will enable the discovery of novel gene regulatory mechanisms in neuroblastoma.
- organism: human
- assay: ChIP-seq
- assay: ATAC-seq
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 78
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A spatial cell atlas of neuroblastoma reveals developmental, epigenetic and spatial axis of tumor heterogeneity
A. G. Patel, O. Ashenberg, … S. J. Rodig·bioRxiv·Jan 7, 2024
- Increased efficacy of histone methyltransferase G9a inhibitors against MYCN-amplified Neuroblastoma
J. Bellamy, K. Malik, … D. Catchpoole·bioRxiv·Nov 22, 2019
- Differentiated neuroblastoma cells remain epigenetically poised for de-differentiation to an immature state
R. Guyer, N. Picard, … A. M. Goldstein·bioRxiv·Jul 10, 2022
- A human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrations
I. M. Saldana-Guerrero, L. F. Montano-Gutierrez, … F. Halbritter·bioRxiv·Nov 21, 2022
- Enhancer hijacking determines intra- and extrachromosomal circular MYCN amplicon architecture in neuroblastoma
K. Helmsauer, M. Valieva, … R. P. Koche·bioRxiv·Dec 20, 2019
- SOX11 is a lineage-dependency factor and master epigenetic regulator in neuroblastoma
B. Decaesteker, A. Louwagie, … F. Speleman·bioRxiv·Aug 21, 2020